GlassScriptPhysician profile
Thomas Corbin Mullis
NPI 1174743918
$1,519.25
in general payments reported to CMS, 2019-2025
16 companies · $369 in 2025
The $369 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $35.74 · 2020: $53.96 · 2021: $446 · 2022: $92.95 · 2023: $268 · 2024: $254 · 2025: $369.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $891.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $890.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $297.74 | 2021-2023 | Pteye Parathyroid Detection System |
| Regeneron Healthcare Solutions, INC. | $292.14 | 2021-2025 | Libtayo, Dupixent |
| Intersect Ent, INC. | $181.73 | 2019-2021 | |
| Aerin Medical INC. | $166.41 | 2022-2024 | |
| Genzyme Corporation | $130.37 | 2023-2025 | |
| Stryker Corporation | $104.24 | 2022-2023 | Xpress Ent Dilation System, Entellus Medical Reinforced Anesthesia Needle, Audion Et Dilation System |
| Glaxosmithkline, LLC. | $79.27 | 2025 | Nucala |
| Integra Lifesciences Corporation | $61.16 | 2024-2025 | Inspira Air, Acclarent Aera, Relieva Spinplus Nav |
| Hikma Pharmaceuticals USA | $41.09 | 2023-2024 | Ryaltris |
| Astrazeneca Pharmaceuticals LP | $36.05 | 2025 | Tezspire |
| Alk-Abello, INC | $27.72 | 2020 | |
| Inspire Medical Systems, INC. | $25.76 | 2025 | Inspire |
| Aroa Biosurgery Incorporated | $20.04 | 2025 | |
| Davol INC. | $19.68 | 2024 | Arista Ah Flexitip |
| Ambu INC. | $18.44 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acclarent, INC | $17.41 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Mullis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.